secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0000950170-24-072534
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos shareholders approve reverse stock split (1:5-1:15) and authorized share increase to 50M
--------------------------------------------------------------------------------

- Stockholders approved reverse stock split at ratio between 1-for-5 and 1-for-15, at Board's discretion, effective June 12, 2024.
- Authorized shares of common stock increased from 34,666,667 to 50,000,000.
- Five directors elected: Curtis Hogue Jr., Robert Hofmeister, Robert Postma, Jaime Vieser, Holger Weis.
- Advisory vote on executive compensation passed with 1,851,846 for and 1,032,789 against.
- Ratification of RSM US LLP as independent auditor for FY 2024 approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024072534/0000950170-24-072534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024072534/tcrt-20240606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-072534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer